Survival Analysis in R
Kaplan-Meier estimates of cumulative overall survival a | Open-i
Metronomic therapy is an effective salvage treatment for heavily pre-treated relapsed/refractory multiple myeloma | Haematologica
Prognostic Impact of Immune-related Adverse Events in Gastric Cancer Patients Treated With Nivolumab | Anticancer Research
Entropy | Free Full-Text | Focused Information Criterion for Restricted Mean Survival Times: Non-Parametric or Parametric Estimators
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer | NEJM
Introduction to Survival Data
Long-term survival and quality of life after intensive care for patients 80 years of age or older | Annals of Intensive Care | Full Text
27 Survival analysis | The Epidemiologist R Handbook
Depressive symptoms in relation to overall survival in people with head and neck cancer: A longitudinal cohort study - Jansen - 2018 - Psycho-Oncology - Wiley Online Library
Emergency resection is an independent risk factor for decreased long-term overall survival in colorectal cancer: a matched-pair analysis | World Journal of Surgical Oncology | Full Text
Assessing CAR T-Cell Therapy Response Using Genome-Wide Sequencing of Cell-Free DNA in Patients With B-Cell Lymphomas - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy
The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study - The Lancet Public Health
Overall survival from date of LMD relapse. Median survival 39 days (95%... | Download Scientific Diagram
A Cumulative of overall survival over 28 days between severe patients... | Download Scientific Diagram
Overall survival in advanced epidermal growth factor receptor mutated non-small cell lung cancer using different tyrosine kinase inhibitors in The Netherlands: a retrospective, nationwide registry study - The Lancet Regional Health –
Real-World Progression-Free Survival as an Endpoint in Advanced Non-Small-Cell Lung Cancer: Replicating Atezolizumab and Docetaxel Arms of the OAK Trial Using Data Derived From Electronic Health Records | medRxiv
Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis | BMC Cancer | Full Text
Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC | NEJM
27 Survival analysis | The Epidemiologist R Handbook
Chapter 20 Survival Analysis | Econometrics for Business Analytics
The impact of the time to start radiation therapy on overall survival in newly diagnosed glioblastoma | Journal of Neuro-Oncology
